| Gemigliptin, Dapagliflozin, Empagliflozin DDI Study (NCT03565458) | LG Chem | 2018-04-05 |
| AsiDNA (a DNA Repair Inhibitor) Administered IntraVenously in Advanced Solid Tumors (NCT03579628) | Valerio Therapeutics | 2018-04-05 |
| A Dose-escalation Clinical Trial After Multiple Dosing of HL217 Eye Drop in Healthy Male Subjects (NCT03648346) | Hanlim Pharm. Co., Ltd. | 2018-04-04 |
| The Clinical Research of Anti-CD20 CAR-T Cells in Patients With Refractory or Relapsed B Lymphocyte Lymphoma (NCT03576807) | Xin Wang | 2018-04-04 |
| A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer (NCT03509636) | Jiangsu HengRui Medicine Co., Ltd. | 2018-04-04 |
| An Open-Label Study to Assess Safety (NCT03645499) | Sun Pharmaceutical Industries, Inc. | 2018-04-04 |
| Bioavailability Study of Amitriptyline Hydrochloride Tablets (NCT03646526) | First Affiliated Hospital of Zhejiang University | 2018-04-04 |
| PET Imaging of Phosphodiesterase-4 (PDE4) in Brain and Peripheral Organs of McCune-Albright Syndrome (NCT02743377) | National Institute of Mental Health (NIMH) | 2018-04-04 |
| Study of GNS561 in Patients With Liver Cancer (NCT03316222) | Genoscience Pharma | 2018-04-04 |
| A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211(Efocipegtrutide) (NCT03374241) | Hanmi Pharmaceutical Company Limited | 2018-04-04 |
| Effectiveness and Clinical Mechanism of Huanglian-Jiedu Decoction in Patients With Intense-exuberant Stomach Fire Syndrome (NCT03469232) | China Academy of Chinese Medical Sciences | 2018-04-04 |
| A Study to Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer (NCT03548467) | Nykode Therapeutics ASA | 2018-04-04 |
| Study of ET190L1 ARTEMIS™ T Cells in Relapsed and Refractory CD19+ Non-Hodgkin's Lymphoma (NCT03379493) | Eureka Therapeutics Inc. | 2018-04-04 |
| Feasibility of Aromatherapy in an Awake Craniotomy Environment (NCT03328143) | Wake Forest University Health Sciences | 2018-04-03 |
| Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 in Healthy Volunteers (NCT03492385) | SFJ Pharmaceuticals, Inc. | 2018-04-03 |
| Sequential Treatment of Extra-Corporeal Shock Wave Combined With aUtologous Bone marRow Mesenchymal Stem Cells on Patients With ischEmic Heart Disease : the S-CURE Study (NCT03397095) | Shanghai 10th People's Hospital | 2018-04-03 |
| Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Participants With Relapsed and Refractory Multiple Myeloma (NCT03486067) | Celgene | 2018-04-03 |
| Compare Efficacy of Oxytocin Administrations on Postpartum Uterine Contractility (NCT02908126) | Oxytone Bioscience BV | 2018-04-03 |
| DBPC Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine in Subjects With Urinary Incontinence (NCT03397771) | Ixaltis SA | 2018-04-03 |
| Investigation of Arrhythmogenic Effect of NPC-15 (NPC-15-7) (NCT03475459) | Nobelpharma | 2018-04-03 |
| Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer (NCT03246074) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-04-03 |
| Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function (NCT03417778) | Gilead Sciences | 2018-04-03 |
| Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma (NCT03440567) | City of Hope Medical Center | 2018-04-02 |
| Thiamine Supplementation in Heart Failure: a Pilot Randomized Controlled Crossover Trial (NCT03228030) | Hamilton Health Sciences Corporation | 2018-04-02 |
| An Open Label, Single-Dose Study of 14C-NW-3509 in Healthy Male Subjects (NCT03446274) | Newron Pharmaceuticals SPA | 2018-04-02 |
| Utilization of Confocal Microscopy During Cardiac Surgery (NCT03189134) | Aditya Kaza | 2018-04-02 |
| Atrial Functional Mitral Regurgitation Response In Mitral Loop Cerclage Annuloplasty (AFRICA Study) (NCT03453853) | Tau-MEDICAL Co., Ltd. | 2018-04-02 |
| A Study to Evaluate ICP-022 in Patients With R/R Mantle Cell Lymphoma (MCL) (NCT03494179) | Beijing InnoCare Pharma Tech Co., Ltd. | 2018-04-02 |
| DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein (NCT03368196) | Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company | 2018-04-02 |
| To Explore the Pharmacokinetics and Relative Bioavailability of Sulfatinib Capsules in Two Different Manufacturers (NCT03483259) | Hutchison Medipharma Limited | 2018-04-02 |
| A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination Chemotherapy (NCT03454620) | Green Cross Corporation | 2018-04-02 |
| A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer (NCT03423628) | AstraZeneca | 2018-04-02 |
| Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Solid Tumors (NCT03472352) | Hangzhou Converd Co., Ltd. | 2018-04-01 |
| Phase I Study to Evaluate the Safety of Dexibuprofen 200mg Under Fasting and Fed Conditions (NCT02956525) | Apsen Farmaceutica S.A. | 2018-04-01 |
| Using Ultrasonography, Shear Wave Elastography, Strain Imaging, and 3-D Volume Ultrasonography on Cardiovascular Disease (NCT03335020) | Mayo Clinic | 2018-04-01 |
| Effect of N_Acetylcysteine on Liver Functions in Donors in Living Liver Transplantation (NCT03634566) | Ain Shams University | 2018-04-01 |
| PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers. (NCT03283943) | British Columbia Cancer Agency | 2018-04-01 |
| Combined PD-1 and CCR5 Inhibition for the Treatment of Refractory Microsatellite Stable mCRC (NCT03274804) | University Hospital Heidelberg | 2018-04-01 |
| The Effectiveness of Vancomycin in Comarison With Cefazolin in Prevention of SSI After Craniotomy (NCT03466645) | Isfahan University of Medical Sciences | 2018-04-01 |
| Quality of Life Improvements With Cord Blood Plasma (NCT03229785) | Hexagon Therapies, LLC | 2018-04-01 |
| Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1) (NCT03392545) | Beijing Tiantan Hospital | 2018-04-01 |
| Effects of 3% Sodium Chloride on Post-operative Dysphagia Following Anterior Cervical Spine Surgery (NCT03677310) | University of Missouri-Columbia | 2018-04-01 |
| Safety, Tolerability, and Anti-cancer Activity of KAHR-102 (The Study Drug) for the Treatment of Lymphoma Patients (NCT02545361) | Kahr Medical | 2018-04-01 |
| Stage Ib Trial of mSMART With Varenicline (NCT03069768) | Duke University | 2018-04-01 |
| Minnelide in Adult Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT03347994) | Justin Watts | 2018-04-01 |
| Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris (NCT03342573) | Mayo Clinic | 2018-04-01 |
| Safety and PK Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Minocin IV (NCT03291158) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2018-04-01 |
| Safety and Efficacy Study of Mesenchymal Stem Cell in Treating Kidney Fibrosis (NCT03460223) | Nanjing Medical University | 2018-04-01 |
| Clinical Trial of Stem Cell Based Tissue Engineered Laryngeal Implants (NCT01977911) | University College, London | 2018-04-01 |
| N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer Patients (NCT03492047) | Ain Shams University | 2018-04-01 |
| A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL (NCT03239392) | Bioniz Therapeutics | 2018-04-01 |
| PET Study With [89Zr]-Df-CriPec® Docetaxel (NCT03712423) | Amsterdam UMC, location VUmc | 2018-04-01 |
| Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Gastrointestinal Cancer (NCT03474861) | Hangzhou Converd Co., Ltd. | 2018-04-01 |
| Phase Ib, Administration the IOP Injection for MRI Contrast Agent in Healthy Subjects (NCT03399214) | MegaPro Biomedical Co. Ltd. | 2018-04-01 |
| A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function (NCT03482024) | Eli Lilly and Company | 2018-03-30 |
| A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer (NCT03424005) | Hoffmann-La Roche | 2018-03-30 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 After Intravenous Administration in Healthy Volunteers (NCT03500627) | Orpheris, Inc. | 2018-03-30 |
| Pediatric Transcranial Static Magnetic Field Stimulation to Improve Motor Learning (NCT03949712) | University of Calgary | 2018-03-30 |
| Assessing an Oral EGFR Inhibitor,YK-209A in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR (NCT05767866) | Suzhou Puhe Pharmaceutical Technology Co., LTD | 2018-03-30 |
| Repeated Subarachnoid Administrations of hUC-MSCs in Treating SCI (NCT02481440) | Limin Rong | 2018-03-30 |
| Study to Evaluate Safety, Tolerability & PK of rhNGF in Healthy Volunteers (NCT03836859) | Dompé Farmaceutici S.p.A | 2018-03-30 |
| Three Way Crossover Closed Loop Study With Xeris Glucagon (NCT03424044) | Oregon Health and Science University | 2018-03-29 |
| A Study to Investigate BAY2402234, a Dihydroorotate Dehydrogenase (DHODH) Inhibitor, in Myeloid Malignancies (NCT03404726) | Bayer | 2018-03-29 |
| TCR-Redirected T Cell Treatment in Patients With Recurrent HBV-related Hepatocellular Carcinoma Post Liver Transplantation (NCT04677088) | Xiaoshun He | 2018-03-29 |
| CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin (NCT03002805) | CBA Research | 2018-03-29 |
| Evaluating the Safety, Tolerability, and Pharmacokinetics of BIIB095 in Healthy Participants (NCT03454126) | Biogen | 2018-03-29 |
| Pretomanid in Adults With Hepatic Impairment (NCT02422524) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-03-29 |
| Olmutinib 600 mg QD in Patients With T790M-positive NSCLC After Treatment With an EGFR-TKI (NCT04510415) | Hanmi Pharmaceutical Company Limited | 2018-03-29 |
| A Study to Assess the Safety, Tolerability, and Efficacy of ST-400 for Treatment of Transfusion-Dependent Beta-thalassemia (TDT) (NCT03432364) | Sangamo Therapeutics | 2018-03-29 |
| Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies (NCT03397706) | Viracta Therapeutics, Inc. | 2018-03-29 |
| Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers (NCT03504475) | Beijing Tongren Hospital | 2018-03-29 |
| G1T38, a CDK 4/6 Inhibitor, in Combination With Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer (NCT03455829) | G1 Therapeutics, Inc. | 2018-03-29 |
| Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML) (NCT03315039) | Moleculin Biotech, Inc. | 2018-03-28 |
| A Study of ADXS-NEO Expressing Personalized Tumor Antigens (NCT03265080) | Advaxis, Inc. | 2018-03-28 |
| A Single Oral Dose Study to Evaluate Four Different Formulations of AZD9977 and the Effect of Food in Healthy Male Subjects (NCT03450759) | AstraZeneca | 2018-03-28 |
| A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-788 Followed by Evaluation of the Effects of a Low-Fat Meal on TAK-788 PK and Evaluation of Relative Bioavailability of TAK-788 Capsules in Healthy Participants (NCT03482453) | Millennium Pharmaceuticals, Inc. | 2018-03-28 |
| BB-101 for Treatment of Diabetic Lower Leg and Foot Ulcers (NCT03888053) | Blue Blood Biotech Corp. | 2018-03-28 |
| Effect of CT1812 Treatment on Brain Synaptic Density (NCT03493282) | Cognition Therapeutics | 2018-03-28 |
| PK Study of Ticagrelor in Children Aged Less Than 24 Months, With Sickle Cell Disease (HESTIA4) (NCT03492931) | AstraZeneca | 2018-03-28 |
| Checkpoint Inhibitor and Radiotherapy for Recurrent Gastric Cancer (CIRCUIT) (NCT03453164) | Fukushima Medical University | 2018-03-28 |
| Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma (NCT03338959) | Fred Hutchinson Cancer Center | 2018-03-28 |
| Stem Cells After Peripheral Mobilization and Harvest (NCT03381599) | Andrews Research & Education Foundation | 2018-03-28 |
| DDI Study Between Dorzagliatin and Rifampicin (NCT04080609) | Hua Medicine Limited | 2018-03-27 |
| Study to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of Padsevonil (NCT03480243) | UCB Biopharma S.P.R.L. | 2018-03-27 |
| Study for Naltrexone on the Abuse Potential of Methylphenidate (NCT03769064) | Avekshan LLC | 2018-03-27 |
| DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia (NCT03358719) | Roswell Park Cancer Institute | 2018-03-27 |
| Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer (NCT03432741) | Mayo Clinic | 2018-03-27 |
| TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms (NCT03503968) | Medigene AG | 2018-03-27 |
| Phase I/II Study of Venetoclax or Lenalidomide in Combination With Ublituximab and Umbralisib in Subjects With Relapsed or Refractory CLL/SLL and NHL (NCT03379051) | TG Therapeutics, Inc. | 2018-03-27 |
| Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV) (NCT03365947) | Arrowhead Pharmaceuticals | 2018-03-27 |
| A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease (NCT03478956) | Hoffmann-La Roche | 2018-03-27 |
| Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors (NCT03447314) | GlaxoSmithKline | 2018-03-26 |
| A Study of LY900014 in Participants With Type 1 Diabetes Mellitus (NCT03465878) | Eli Lilly and Company | 2018-03-26 |
| Exogenous Ketones and Glucose Tolerance (NCT03461068) | University of British Columbia | 2018-03-26 |
| CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies (NCT03448393) | National Cancer Institute (NCI) | 2018-03-26 |
| Single-dose Novel Selective alpha2c Antagonist Pharmaco-MRI Study in Healthy Volunteers (NCT03440021) | University of Cape Town | 2018-03-26 |
| Ixazomib, ONC201, and Dexamethasone in Relapsed/Refractory Multiple Myeloma (NCT03492138) | Ajai Chari | 2018-03-26 |
| Safety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Renal Cell Carcinoma (NCT03393936) | Shanghai PerHum Therapeutics Co., Ltd. | 2018-03-26 |
| A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses in Participants With Chronic Hepatitis B (NCT03439488) | Alios Biopharma Inc. | 2018-03-26 |
| A Study of Lasmiditan on Simulated Driving Performance in Healthy Participants (NCT03459612) | Eli Lilly and Company | 2018-03-26 |